The Hypocrisy of Patent '507

Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases.

Yet this plant is listed Schedule I under the Controlled Substances Act

The following findings are required for drugs to be placed in this schedule:[2]

1. The drug or other substance has a high potential for abuse.
2. The drug or other substance has no currently accepted medical use in treatment in the United States.
3. There is a lack of accepted safety for use of the drug or other substance under medical supervision.

Except as specifically authorized, it is illegal for any person:

1. to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or
2. to create, distribute, or dispense, or possess with intent to distribute or dispense, a counterfeit substance.[3]

The Hypocrisy is outrageous!